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ABSTRACT 
 
The thymus is the primary organ for the production of T cells, critical for the generation of 
adaptive immune responses. T cell progenitors proceed through a series of developmental 
stages, including selection, lineage commitment and maturation in the thymus, in order to 
differentiate into functional CD4 helper or CD8 cytotoxic T cells. The decision to commit into 
either lineage is known to involve T-cell receptor (TCR) binding, cytokine signaling and lineage-
specific transcriptions factors, and is believed to be virtually irreversible. 
Here, we report a role for IL-4 in the plasticity of CD4 single positive (CD4SP) thymocytes. 
We showed that IL-4 has the capacity to induce CD8α and CD8β upregulation in CD4SP 
thymocytes, generating mature double positive (DP) and CD8SP thymocytes, and further 
investigate the mechanism underlying this co-receptor reversal.  
CD8 upregulation in purified CD4SP thymocytes was not dependent on cell proliferation, as 
a significant proportion of the CD8+ cells generated had not divided in culture. CD8 
upregulation was very low in the presence of IL-2, while IL-7 generated some DP but few 
CD8SP cells. IL-13, a cytokine that shares IL4Rα signaling with IL-4, did not increase CD8 
expression in CD4SP thymocytes. Of note, IL-4 did not have an impact on CD4 expression 
when added to CD8SP thymocytes.  
IL-4-induced co-receptor reversal was observed even when CD4SP cells expressed the 
human maturation and egress markers CD27 and CD45RA, respectively, though to a lesser 
extent. In agreement, IL-4 induced lower upregulation of CD8 expression in CD4 T cells from 
cord blood. Notably, this ability was lost in CD4 T cells from adult blood, thus confirming a 
gradual loss of upregulation capacity from the human thymus towards the periphery. 
CD8SP cells generated from CD4SP thymocytes upon IL-4 exposure appear to be bona fide 
CD8 T cells, as CD8 expression was stable upon IL-4 removal from culture. This was not 
observed for DP cells, which depended on the presence of IL-4 to maintain CD8 expression. 
Furthermore, the transcriptional pattern of IL-4-induced CD8SP cells in culture supported the 
modulation of lineage-specific genes towards CD8 commitment, as revealed by the decrease 
in the transcriptional levels of CD4 and ThPOK and the increase of CD8.  
Moreover, we found that IL-4 was expressed in the medulla of the human thymus, in 
agreement with a possible physiological role for IL-4 in T cell development.  
Collectively our results support a role for IL-4 in human T cell development and differentiation, 
specifically in driving co-receptor reversal in CD4SP thymocytes, a mechanism unknown until 
now. Additionally, this system provides a valuable model for the study of the regulation of T 
cell lineage commitment in the human thymus, and merits further study. 
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RESUMO 
 
Os progenitores de células T sofrem uma série de transformações durante o seu 
desenvolvimento incluindo seleção, comprometimento para uma determinada linhagem (CD8 
ou CD4) e maturação no timo de modo a poderem diferenciar-se em células T funcionais CD4 
auxiliares  ou CD8 citotóxicas. A decisão de se diferenciar numa das duas linhagens envolve 
o recetor de células T (TCR), sinalização por parte de interleucinas (IL) e fatores de transcrição 
(TF) específicos para cada linhagem, crendo-se, atualmente, ser um processo vitualmente 
irreversível.   
Compreender as bases que fundamentam a decisão de uma célula se diferenciar numa 
determinada linhagem é de extrema importância para a compreensão dos mecanismos 
envolvidos no desenvolvimento dos timócitos humanos. Deste modo, este modelo é dos mais 
debatidos em imunologia apesar de se recorrer maioritariamente ao modelo animal do ratinho 
que, apesar de ter proporcionado um vasto leque de conhecimentos, nem sempre se aplicam 
ao modelo humano, raramente estudado.  
O modelo de sinalização cinética definido em ratinho para explicar o desenvolvimento dos 
timócitos aponta para a IL-7 como força motriz na especificação e diferenciação em células 
CD8, sendo a sua ausência durante o desenvolvimento no timo responsável pela manutenção 
do fenótipo CD4 definido nos estadios mais precoces de maturação. A IL-4 tinha já sido 
testada no modelo do ratinho tendo tido fraco desempenho no sentido de conduzir à 
diferenciação dos timócitos em células T CD8 quando comparada com a IL-7. 
A IL-4, membro da família de recetores com cadeia γ, foi originalmente descrita em 1982 
como sendo uma citocina pleiotrópica de tipo I produzida maioritariamente por linfócitos T 
auxiliares do tipo 2 (Th2), basófilos, eosinófilos, mastócitos, células natural killer (NK), células 
T foliculares (Tfh) e células T γ/δ. Esta citocina tem a função de induzir a polarização do 
fenótipo Th2 e suprimir a diferenciação das células Th1. Adicionalmente, a IL-4 promove o 
crescimento e diferenciação dos linfócitos B, controlando a especificidade das alterações de 
classe de imunoglobulinas tal como o desenvolvimento de células B de memória. 
As funções fisiológicas desta citocina são mediadas pelo recetor de IL-4, composto por uma 
cadeia α de 140kDa e uma cadeia γ partilhada com os recetores das citocinas IL-2, IL-7, IL-9 
e IL-15. Este dímero pode ser encontrado em células hematopoiéticas ativadas 
exclusivamente após ligação da IL-4. Após ligação da IL-4 ao seu recetor é promovida 
ativação do ativador de transcrição e transdutor de sinal 6 (STAT6), que por sua vez promove 
a regulação de genes responsáveis pela diferenciação de células T CD4 ativadas em células 
Th2 e Th9, expressão de GATA binding protein 3 (GATA3), produção de quimiocinas e pelo 
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aumento da expressão da imunoglubina IgE responsável pelo desenvolvimento de uma 
resposta imunológica alérgica. 
Neste projeto sugerimos um papel para a IL-4 na manutenção da plasticidade dos timócitos 
CD4+CD8- (single positive, CD4SP) em humano. Mostramos que esta citocina apresenta a 
capacidade de induzir a expressão dos co-recetores CD8α e CD8β em timócitos CD4SP, 
gerando timócitos duplos positivos (DP) e CD8SP, e aprofundamos os mecanismos na base 
desta reversão de co-receptores.  
A indução da expressão de CD8 em timócitos CD4SP purificados não mostrou ser 
dependente de proliferação das células uma vez que uma significativa porção de células CD8 
positivas geradas não se dividiu em cultura. A indução da expressão de CD8 foi muito baixa 
na presença de IL-2, enquanto que na presença de IL-7 surgiram DP mas muito poucas 
CD8SP. A IL-13, uma citocina que partilha da sinalização através do recetor α da IL-4, não 
aumentou a expressão de CD8 em timócitos CD4SP. É de notar que a IL-4 não teve qualquer 
impacto na expressão de CD4 quando adicionada a culturas de timócitos CD8SP.  
A reversão de co-receptor induzida pela IL-4 observou-se mesmo no caso de timócitos 
CD4SP já com expressão dos marcadores de maturação e de saída do timo CD27 e CD45RA, 
respetivamente, apesar de apresentarem níveis mais baixos de indução de expressão de CD8 
quando comparados com timócitos CD4SP CD27-.  
Na periferia, a IL-4 foi capaz de induzir expressão de CD8 em células T CD4 provenientes 
do cordão umbilical. É de notar que esta capacidade se perde com células T CD4 provenientes 
de sangue adulto, confirmando assim uma perda gradual desta capacidade de induzir a 
expressão de CD8 desde o timo para a periferia.  
As células CD8SP geradas a partir de  timócitos CD4SP parecem ser verdadeiras CD8, uma 
vez que a expressão deste co-receptor se manteve estável mesmo na ausência de estímulo 
da IL-4 em cultura. O mesmo não se observou no caso das DPs geradas, as quais parecem 
depender do estímulo de IL-4 para manter a expressão de CD8.  
O padrão transcripcional das células CD8SP induzidas pela IL-4 em cultura apoiam uma 
modulação dos genes responsáveis pela especificação da linhagem e comprometimento das 
células T CD8, revelado pela diminuição dos níveis transcripcionais de CD4 e ThPOK e pelo 
aumento dos níveis de CD8.  
Por fim, encontrámos expressão de IL-4 na medula do timo humano, apontando, assim, para 
um possível papel fisiológico desta citocina no desenvolvimento das células T humanas.  
Em estudos futuros pretendemos descobrir qual a via envolvida na sinalização de IL-4 
responsável pela indução da expressão de CD8 em timócitos CD4SP usando inibidores das 
várias vias usadas pela IL-4. Deste modo poderemos identificar a via exata usada pela IL-4 
para induzir a reversão de co-recetor de CD4 para CD8 no decurso do desenvolvimento das 
células T no timo humano.  
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De igual modo, em estudos adicionais pretendemos estudar a capacidade funcional das 
células T CD8 geradas no sentido de determinar se possuem ou não a característica função 
citotóxica, possivelmente através da medição de fatores citolíticos tais como Granzima-B, 
interferão γ (IFN-γ) e Perforina. Outros estudos funcionais podem ser realizados usando linhas 
de células alvo para testar o poder citotóxico das células T CD8 geradas. 
Uma vez que um circuito epigenético estabelece a identidade das linhagens auxiliar vs 
citotóxica, será importante compreender quais os mecanismos epigenéticos a atuar durante a 
diferenciação das células T no timo, tal como quais os mecanismos mediados pela cromatina 
envolvidos no comprometimento CD4/CD8. Determinação da acetilação/metilação do DNA e 
das histonas apresenta-se como um possível método a usar neste sentido. 
O estudo de culturas com pedaços de timo (TOCs) permitirá revelar um possível papel 
fisiológico da IL-4 durante a diferenciação dos timócitos, visto que os pedaços de tecido tímico 
mantêm as células o mais próximo possível do seu ambiente natural com todos os 
mecanismos envolventes intrínsecos, difícil de replicar usando células purificadas. 
Dada a importância da utilização do modelo animal, assumimos a relevância de testar se 
uma semelhante indução de CD8 poderá ocorrer em timócitos de murganho.  
Em suma os nossos resultados revelam um papel da IL-4 no desenvolvimento e 
diferenciação das células T humanas, em especial  na condução da reversão de co-recetor e 
manutenção de um certo nível de plasticidade das células T CD4 do timo humano, algo 
desconhecido até ao momento. Adicionalmente, este sistema providencia um valioso modelo 
de regulação do comprometimento das células T para uma determinada linhagem no timo 
humano, merecendo mais estudo.  
 
Palavras-chave: Desenvolvimento e diferenciação das celulas T humanas; 
Comprometimento das células T para uma determinada linhagem; IL-4; Plasticidade dos 
timócitos CD4SP; Expressão dos co-recetores CD8α e CD8β. 
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ABBREVIATIONS 
 
Abbreviation Description 
ACTB β-actin  
AHR Airway hyperresponsiveness 
APC Antigen-presenting cell 
BM Bone marrow 
CCR7 C-C chemokine receptor type 7 
CD Cluster of differentiation 
c-Kit Mast/stem cell growth factor receptor 
CLP Common lymphoid progenitor 
CMP Common myeloid progenitor 
cTEC Cortical thymic epithelial cell 
DC Dendritic cell 
DN Double negative 
DP Double positive 
EDP Early double-positive 
ERC Epithelial reticular cell 
FACS Fluorescence-activated cell sorting 
FCS Fetal bovine serum 
Flt3 FMS-like tyrosine kinase-3 
FTOC Fetal thymic organ culture 
FVD Fixable viability dye 
GATA3 GATA Binding Protein 3 
Gfp Green fluorescent protein 
GM Granulocyte/monocyte 
GzmB Granzyme B 
HIV Human Immunodeficiency Virus 
HSC Hematopoietic stem cell 
IEL Intraepitlhelial Lymphocyte 
IFN Interferon 
Ig Immunoglobulin 
IL Interleukin 
IL-7R Interleukin 7 receptor 
IONO Ionomycin 
ISP Immature single positive 
KO Knock out 
MC Complete media 
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MHC Complex of major histocompatibility 
Mke Megakaryocyte/erythrocyte 
MPP Multipotent progenitor 
mTEC Medullary thymic epithelial cell 
NK Natural killer 
PBMC Peripheral blood mononuclear cell 
PBS Phosphate-buffered saline 
RAG Recombination activating gene 
RT Reverse transcriptase 
RT-PCR Reverse Transcriptase polymerase chain reaction 
Runx Runt related transcription factor 
SEM Standard error of the means 
SOCS1 Suppressor of cytokine signaling 1 
STAT Signal transducer and activator of transcription 
TCR T cell receptor 
TEC Thymic epithelial cell 
Tfh Follicular helper T cell 
Th Helper T cell 
Th-POK T-helper inducing POZ-Kruppel like factor 
TN Triple negative 
TNF Tumor necrosis factor 
TOC Thymic organ culture 
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1 INTRODUCTION 
 
1.1 Thymus – the primary organ for T cell generation 
T cells are key mediators of cellular immunity. They are highly specialized in the defense 
against bacterial and viral infections, mediate immune surveillance against tumor cells and 
react to foreign tissues. (1)  
The thymus is the organ that supports the differentiation and selection of T cells. Thymic T 
cell development consists of several processes that require the dynamic relocation of 
developing lymphocytes into, within and out of the multiple environments of the thymus (2-4).  
The importance of the thymus is revealed, for example, by the rescue of T-cell deficiency in 
some patients with DiGeorge syndrome (a rare congenital disorder that in some cases is 
characterized by the inexistence of a thymus and parathyroid glands, resulting in complete T-
cell deficiency and severe immunodeficiency) that received transplantation of allogeneic 
thymus tissue (5).  
 
1.2 Thymic structure 
The human thymus is composed of 2 lobes and many lobules. Histologically, it can be 
subdivided into four major compartments with distinct functions that are specific to the 
microenvironment and that guide different stages of T cell development (6). The four 
compartments include the subcapsular zone, the cortex, the medulla, and the cortico medullary 
junction (Figure 1). The subcapsular zone is comprised mainly of cortical thymic epithelial cells 
(cTECs), whereas the cortex contains an abundant mix of cTECs, fibroblasts, and 
macrophages. In the medulla, a stromal network of dendritic cells (DCs) and medullary TECs 
(mTECs) is present, as well as Hassal Corpuscles (HC), which are concentric structures of 
degenerating epithelial reticular cells (ERC). The cortico-medullary junction contains a dense 
network of endothelial cells that allows the entry and exit of thymocytes to and from the blood 
(6).  
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Figure 1. Histology of the human thymus.  The thymus is a primary lymphoid organ composed of two lobes 
divided into many lobules. The outer region is the cortex (C), full of immature lymphocytes undergoing differentiation 
and surrounded by the subcapsular region (SR). The inner lighter region is the medulla (M) where Hassal’s 
corpuscles (HC), which are keratinized degenerated epithelial cells arranged in a concentric layers, are located. 
The cortico medullary junction (CMJ), between the Medulla and the Cortex, allows entry and exit of thymocytes to 
and from the blood. 
 
1.3 T cell differentiation 
Throughout development, bi-potential cells use environmental cues to determine cell fate. 
The mechanisms of lineage decision are currently under intense investigation (7). 
The thymus provides the microenvironment essential for the development of T cells from 
hematopoietic stem cells (HSCs). As the cells residing in the thymus have little self-renewing 
potential, thymopoiesis temporarily depends on continued recruitment of hematopoietic 
precursors from the bone marrow (8). 
T cell progenitors originated in the bone marrow (BM) enter the thymus and undergo a series 
of defined and coordinated developmental stages, including differentiation, selection and 
maturation, in order to become functional T cells. This development through specific stages 
takes place in discrete areas of the thymus and can be identified by tracing the gradual 
alterations in cell-surface marker expression (9). 
 
1.3.1 Early T cell development 
HSCs leave the BM as MPPs (Multipotent progenitors) and undergo the first lineage 
commitment step in the thymus which results in a strict bifurcation of myeloid and lymphoid 
driven lineages (10) originating common myeloid progenitors  (CMPs) and common lymphoid 
progenitors (CLPs) respectively (Figure 2) (11).  CLPs can originate B, T and natural killer (NK) 
cells, but not myeloid cells. In parallel, CMPs differentiate into megakaryocyte/erythrocyte 
(MkE) and granulocyte/monocyte (GM) progenitors. Notch ligands Delta-like 1 and 4, members 
of a highly conserved family of transmembrane receptors, in combination with IL-7 and Flt3 
ligand, are determining factors in the choice between T- and B-cell fate (12-14). 
Bone marrow-derived thymic precursors expressing CD34 (marker of hematopoietic 
progenitors) enter the thymus through the cortico-medullary junction and migrate to the cortical 
region, where interactions with the thymic stroma induce their proliferation and differentiation 
(15, 16).  
Human CD34+ cells committed to the T cell lineage express CD1a but still lack CD4 and 
CD8 coreceptors, and are thus double-negative (DN) cells (Figure 2) (15-17). CD34+CD1a+ 
cells start expressing CD4, but not yet CD8, being therefore referred to as CD4 immature 
single-positive (CD4ISP) cells (or pre T1) (18-20). This population contains precursors of both 
αβ and γδ T cells and is, therefore, upstream of the β-selection checkpoint (21-23). β-selection 
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is the process by which precursor T cells (pre-T1) with a productive rearrangement of the TCRβ 
locus are selected for further differentiation.  
 
1.3.2 Positive and Negative selection 
After β-selection, rearrangements at the TCRα locus are initiated in cells expressing CD4 but 
only one of the two CD8 chains, CD8α giving rise to early double positive (EDP) cells (17). The 
CD8 molecule is composed of two chains, α and β, and is expressed as an αβ (in conventional 
CD8 T cells) or as an αα (such as in CD8αα intra-epithelial lymphocytes - IELs ) dimer. The 
CD8β extracellular domain is important to increase the avidity of CD8 binding to the complex 
of major histocompatibility I (MHC I) enabling pathogen recognition (18).  
Upon CD8αβ expression DP thymocytes undergo a strict selection of functional TCRs that 
can engage self-MHC molecules. Only these cells are signaled to survive and differentiate into 
functionally mature T cells (8). Too little TCR signaling results in apoptosis/death by neglect 
and in return, too much signaling can also promote acute apoptosis (negative selection). The 
proper, intermediate level of TCR signaling will initiate effective maturation also called positive 
selection. Thymocytes that express TCRs that bind self-peptide–MHC class I complexes 
become CD8SP T cells, whereas those that express TCRs that bind self-peptide–MHC class 
II become CD4SP T cells, reallocating in the thymic medulla (24).  
Once thymocytes have completed their development, they exit the thymus into the blood. On 
reaching a peripheral lymphoid organ they leave the blood to migrate through the lymphoid 
tissue, returning to the bloodstream to recirculate between blood and peripheral lymphoid 
tissue until they encounter their specific antigen (17). 
  
Figure 2. T cell development in the thymus. CD34+ precursors originated in the bone marrow populate the 
thymus. Upon commitment to the T-cell lineage, CD34+CD1a− cells start expressing CD1a. Next, T cells express 
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CD4, but not yet CD8, and are referred to as CD4 immature single-positive (CD4ISP) cells. At this stage some cells 
begin rearrangement of their TCR β (pre-T1 cells) and undergo β selection. This stage is followed by cells that 
express CD4 and only one of the two CD8 chains, CD8α, and are referred to as early double-positive (EDP) cells. 
Subsequently, acquisition of a CD8αβ dimer generates DP cells that, in the thymic cortex, interact with cells that 
express MHC molecules. Only a small portion of DP thymocytes survive positive/negative selection and differentiate 
into SP CD4 or CD8 T cells (adapted from Spits et al, 2002) 
 
1.3.3 CD4/CD8 lineage specification 
Thymocytes positively selected differentiate into either CD4 helper T cells or CD8 cytotoxic T 
cells, a critical decision known as CD4/CD8‑lineage choice (25). 
In the mouse model, two classical models of lineage choice were suggested which fall into 
two main categories: ‘stochastic’ - The stochastic selection model; or ‘instructive’ - Strength-
of-signal instructional model and Duration-of-signal instructional model, assuming, 
respectively, a random or an instructed termination of co-receptor transcription. Both models 
agree on some fundamental principles such as: positive selection and lineage commitment are 
simultaneous events that are induced by the same TCR signals, which can selectively 
terminate either Cd4 or Cd8 gene expression, a process known as lineage commitment (25). 
The currently accepted, Kinetic signaling model, is a non-classical model best explaining the 
CD4/CD8-lineage choice (Figure 3) (25, 26, 27). This model proposes that CD4/CD8-lineage 
choice is defined by TCR-signal duration, in contradiction with the first models, and that 
cytokines of the common cytokine receptor γ-chain (γc) family, such as IL­7, serve as sensors 
that detect the duration of the TCR signal (26, 28, 29). This model suggests that cytokine-
unresponsive DP thymocytes become cytokine-responsive intermediate thymocytes that are 
transcriptionally Cd4+Cd8−, since Cd8 gene transcription is terminated, upon TCR-mediated 
positive selection (26, 28, 29). In the case of persistent TCR-mediated signals, and in the 
absence of Cd8 gene transcription, thymocytes differentiate into CD4 T cells. If, in the absence 
of Cd8 transcription, TCR-mediated signalling ceases promoting signaling by intrathymic γc 
cytokines such as IL-7, the cells differentiate into CD8 T cells. 
In this sense, assessment of TCR-signalled thymocytes can identify cell fate, once MHC class 
II-restricted TCR signaling does not depend on Cd8 gene transcription. In contrast, signaling 
by MHC class I-restricted TCRs is dependent on CD8 and so would cease in the absence of 
Cd8 gene transcription (25). 
For uncommitted Cd4+Cd8– intermediate thymocytes to differentiate into CD8+ T cells, they 
must terminate Cd4 gene transcription and reinitiate Cd8 gene transcription, a process 
designated ‘co­receptor reversal’. This process is, in fact, the foundation of the kinetic 
signalling model uncouvering the dependence of signalling by IL-7 and possibly other 
intrathymic γc cytokines during T cell development and lineage choice (28-31). 
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In respect to previous studies, DP thymocytes are in truth unresponsive to intrathymic 
cytokines such as IL- 7 and IL-4 (31, 32), but solely before receiving a TCR signal. Moreover, 
although DP thymocytes are located in the thymic cortex, which lacks IL-7-producing cells, 
induction of Il7r and Ccr7 expression allow TCR-signaled DP thymocytes to migrate into 
cytokine-rich areas of the thymus (such as the cortico medullary junction and thymic medulla) 
and to bind IL-7 allowing differentiation of DP thymocytes into mature T cells (33, 34).  
Overall, in the mice model, TCR-mediated positive selection converts DP cells into cytokine-
responsive thymocytes, though, differentiation into cytotoxic-lineage T cells relies on the 
following signaling by intrathymic cytokines.  
 
Figure 3. The kinetic signaling model of CD4/CD8 lineage specification. Positively selecting TCR signals 
induce DP thymocytes to terminate Cd8 gene expression and to convert into CD4+CD8– intermediate thymocytes. 
Persistence of TCR signaling blocks IL‑7‑mediated signaling and induces differentiation into mature CD4 T cells. 
Cessation or disruption of TCR signaling allows IL‑7‑mediated signaling, which induces CD4+CD8– intermediate 
thymocytes to undergo co‑receptor reversal, gain a CD4–CD8+ phenotype and differentiate into CD8 T cells (from 
Singer et al, 2008).  
 
1.4 Human T cell differentiation 
Regarding human T cell differentiation, phenotypic analysis using  hybrid fetal thymic organ 
cultures (FTOC) revealed the markers specifying each phase of late T cell differentiation (17). 
Upon acquirement of a rearranged αβ TCR, immature double-positive (I-DP)  cells arise 
lacking the early activation antigen CD69 marker (Figure 4). After positive selection, 
expression of CD69 is upregulated. Two populations CD69+CD27− arise: the CD4+CD8+ (II-
DP) cells that fail to develop further, and the CD69+CD4+ cells (II-CD4SP), with low levels of 
CD8, which are the precursors for both CD4 and CD8 SP T cells. Next, the surface CD3-TCR 
and CD27 (marker of commitment to the helper lineage) markers are upregulated and the 
CD69+CD27+CD4+ (III-CD4SP) cells differentiate into CD4SP T cells. Both CD4SP and CD8 
SP cells then loose CD1a expression, related with the acquisition of in vitro expansion capacity 
and the production of high levels of cytokines, determining functional maturation. SP cells 
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finally acquire the egress marker CD45RA (V-SP stage) and still express low levels of CD69, 
expression that will be lost when the cells migrate out of the thymus (17).  
 
 
Figure 4. Model of late differentiation/maturation of T cells in the human thymus. In this model the sequential 
steps of T cell differentiation and maturation of single-positive cells are defined by cell-surface markers. Immature 
DP T cells start by acquiring the early activation antigen CD69 marker of positive selection. Acquisition of CD27 in 
CD4SP thymocytes marks the commitment toward the helper-lineage. Upon completion of the T cell development 
both CD4SP and CD8SP thymocytes express the naïve T cell marker CD45RA enabling the migration of thymocytes 
into the blood (from Spits et al, 2002). 
 
1.5 Transcription factors regulating lineage choice 
In humans, the signals involved in lineage decision are poorly defined but, in mice, the 
transcription factors that specify CD4 or CD8 lineage choice in positively selected thymocytes 
have largely been identified: CD4 lineage choice is specified by the zinc-finger transcription 
factor ThPOK (35-37), whereas CD8 lineage choice is specified by the Runt-family 
transcription factor Runx3 (38-40). ThPOK and Runx3 negatively regulate each other’s 
expression, thus reinforcing lineage choices (35-39).  
In agreement with predictions of the kinetic signaling model, persistent TCR MHC class II-
restricted signaling in DP thymocytes induce ThPOK expression, upregulating the GATA 
binding protein 3 (GATA3) and preventing CD4 silencing, thus specifying CD4 lineage choice 
(Figure 5) (41-43). Alternatively, if positively selecting MHC class I restricted TCR signals are 
disrupted or cease, there is subsequential loss of GATA3 and ThPOK expression. Also, IL-7R 
signaling and Runx3 expression are upregulated (25).  
ThPOK, a zinc-finger protein encoded by the zbtb7b gene, appears to be required and 
sufficient in determining CD4-lineage choice. Consistent with this perspective, retroviral 
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transduction of mature CD8 T cells with ThPOK led to decreased T-cell cytotoxicity and 
induced CD4 T-helper-cell characteristics, indicating that ThPOK can induce the helper-
lineage even in mature CD8 T cells (35-39). When the developmental potential of CD4 
thymocytes to express ThPOK at intermediate or high levels was tested in vitro, CD4-CD8+ T 
cells emerged specifically from the cells expressing intermediate amounts of ThPOK. Thus, 
simple induction of ThPOK expression is insufficient for full commitment to the helper lineage, 
relying on the escalation of ThPOK levels (44). ThPOK as also an effect in both Cd4 and Cd8 
gene transcription. It maintains Cd4 gene transcription by preventing factors, such as Runx3, 
from silencing it, while it decreases Cd8 gene expression by downregulating the enhancer 
activity of e8I (43). 
It was revealed that Runx proteins also bind to a sequence in the ThPOK gene inhibiting its 
expression. Runx3 is able to bind to the Cd4 silencer element and silences Cd4 gene 
transcription (40, 45). Indeed, Runx protein deficiency results in Cd4 gene de-repression (45, 
46), whereas overexpression of a Runx3 transgene downregulates Cd4 gene transcription (47, 
48). Current evidence demonstrates that Runx3 also associates with genes encoding 
Granzyme B, Perforin and interferon-γ (IFNγ) characteristic of cytolytic CD8 effector cells (49).  
The factors that promote Runx3 activation are poorly known, though, STAT5, which acts 
downstream of IL-7 signaling, is thought to promote Runx3 expression after cessation of TCR 
signaling in post-selected thymocytes (50). 
GATA3, an enhancer binding zinc finger protein, functions as a lineage specific transcription 
factor in T cells at various stages of development (51, 52). GATA3 is expressed in the earliest 
progenitor T cells and is required for thymocytes to differentiate beyond the DN stage of 
development (52). The GATA3 role in CD4 lineage choice is revealed by its upregulation by 
TCR signaling in DP thymocytes and its sustained expression blocks the generation of CD8+ 
T cells (53). However, unlike ThPOK, GATA3 does not seem to be a CD4 lineage specifying 
factor because forced expression of GATA3 does not redirect MHC class I-restricted 
thymocytes to differentiate into CD4+ T cells. In fact, as it is expressed in positively selected 
thymocytes earlier than either ThPOK or Runx3, GATA3 might function upstream of these 
other factors. Indeed, the lack of ThPOK expression in post-selection GATA3-deficient 
thymocytes and the presence of GATA3 binding at two regions in the ThPOK gene provides 
further evidence of its upstream role (51-52).  
 
1.5.1 Maintenance of lineage commitment 
Regarding the role of ThPOK in maintaining commitment of peripheral CD4 cells to the helper 
T lineage, other studies revealed, upon transfer into immunodeficient recipients, CD4 T cells 
from which Thpok had been conditionally excised, upregulated genes characteristic of the 
cytotoxic T lineage, including Cd8 and Granzyme B (GzmB). This finding revealed that 
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continuous extrathymic expression of ThPOK is necessary to maintain helper-lineage gene 
signatures, which are established during differentiation in the thymus (37). 
Also, although the intronic Cd4 silencer is essential to establish the initial repressive state at 
Cd4 during CD8 lineage commitment in the thymus, this repression is maintained after removal 
of the silencer from mature CD8 T cells in the periphery by epigenetic mechanisms in place in 
peripheral cells that maintain Cd4 silencing (54). In opposition, the epigenetic mechanisms 
regulating repression of Cd8 during helper-lineage specification remain unclear. 
A recent study suggested a potential form of lineage plasticity in the mice gut. Upon transfer 
of naïve CD4 T cells containing the Thpok-gfp reporter allele into lympho-deficient RAG KO 
mice, some cells down-regulated Thpok-gfp re-expressing CD8α in the small and large 
intestine, but not in other peripheral lymphoid tissues. This recovery of Cd8 co-receptor was 
independent of MHC-restriction and confirmed by in vivo fate mapping showing that 
CD4+CD8αα+ IEL differentiate from CD4 lineage cells under normal conditions (55). This 
experiment also confirms the importance of lineage decision regulating genes such as ThPOK 
and its capacity of reverting lineage decision even in the periphery.  
Another experiment tried, in conventional CD4 T cells, overexpression/upregulation of Runx3 
and endogenous RUNX3, but failed to downregulate ThPOK (56). 
Overall, current evidence support an antagonistic interplay between ThPOK and Runx3 as 
the master regulators of lineage decision. This negative feedback acts as the crucial 
mechanism controlling helper versus cytotoxic fate decision and seems to be an evolutionary 
strategy for the emergence of new developmental branch points from ancestral progenitors. 
 
Figure 5. Signaling and transcriptional regulation of CD4/CD8 lineage fate choice. During positive selection, 
TCR signals upregulate GATA3 and ThPOK expression. GATA3 upregulation is important for the differentiation of 
CD4+CD8low thymocytes into CD4 T cells. ThPOK expression in TCR‑signaled thymocytes, upregulated by 
persistent TCR signaling, is required for CD4‑lineage commitment and for preventing Cd4 gene silencing by Runx 
proteins. Runx expression may be upregulated by interleukin‑7 receptor (IL‑7R) signaling (from Singer et al, 2008). 
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1.6 CD4-helper T cells 
CD4 T cells play central roles in mediating adaptive immunity to a variety of pathogens. These 
cells help B cells generating antibodies (Figure 6A), enhance and maintain responses of CD8 
T cells and regulate macrophage function. Helper cells control immune responses against a 
wide range of pathogenic microorganisms, and regulate/suppress immune responses both to 
control autoimmunity and to adjust the magnitude and persistence of responses (57).  
Additionally, CD4 T cells are central mediators of immunologic memory, meaning that 
decreased numbers of CD4 T cells induce function loss rendering the individual susceptible to 
an extensive range of infectious diseases. For example, in HIV infection, as CD4 T cell 
numbers in blood fall, opportunistic infections are most likely to occur. 
 
1.7 CD8-cytotoxic T cells 
CD8 T cells are also key mediators of adaptive immunity. These cytotoxic T cells, which are 
important for directly killing cancerous or virally infected cells (Figure 6B), are of particular 
interest for vaccine development to induce potent CD8 T cell-mediated cytotoxic responses to 
viruses and tumor cells (58). 
 Activation and differentiation of naïve CD8 T cells into cytotoxic effector cells requires help 
from CD4 T-helper cells. There is a first interaction of the TCR complex with antigenic peptide 
and MHC-I on antigen-presenting cells (APCs) followed by a second costimulatory signal that 
promotes CD8 responses, including secretion of cytokines such as tumor necrosis factor-α 
(TNF-α) and IFN-γ, which have anti-tumor and anti-viral microbial effects. 
 
   
 
Figure 6. CD4 vs CD8 T cell response. A. CD4-helper responses. APCs present antigens to CD4 T cells through 
MHC Class II molecules inducing cell activation. Activated Th cells promote B cell priming and antibody production. 
Also, memory B cells arise from this interaction B. CD8-cytotoxic response. CD8 T cells express a dimeric co-
receptor, CD8, composed of one CD8α and one CD8β chain. These cells recognize peptides presented by MHC 
Class I molecules binding to this molecule and become activated, responding with secretion of cytokines, primarily 
TNF-α and IFN-γ, which have anti-tumor and anti-viral microbial effects (from Wolfert, M.A. et al, 2013). 
 
A B 
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1.8 Role of IL-4 in immunity 
Interleukin 4 (IL-4), a short four-helix bundle peptide member of the γ-chain receptor cytokine 
family, originally described in 1982, is a pleiotropic type I cytokine produced mainly by Th2 
lymphocytes, basophils, and mast cells in response to receptor-mediated activation (59-60). 
Other cell types that can produce IL-4 include NKT cells, a specialized subset of T cells that 
express NK1.1 and CD1, eosinophils, follicular T helper cells (Tfh) and γ/δ T cells (61).  
Classically, IL-4 drives CD4 T cell polarization in the Th2 phenotype together with 
suppression of Th1 cells (62). IL-4 also supports the growth and differentiation of B 
lymphocytes, controlling the specificity of the immunoglobulin G (IgG) class switching and the 
development of memory B cells.  
The physiologic functions of IL-4 are mediated by the IL-4 receptor (IL-4R) complex (Figure 
7). Several studies have demonstrated the existence of two types of IL-4 receptors.  The type 
I receptor complex comprises a 140-kDa chain (the IL-4Rα chain) and the γ-common chain, 
which is also shared by IL-2, IL-7, IL-9, and IL-15 receptors (63). This is the prevailing 
heterodimer in hematopoietic cells and is activated exclusively upon IL-4 binding. The IL-4Rα 
chain may also heterodimerize with the IL13Rα1 chain to form the type II receptor, which is 
able to transduce both IL-4 and IL-13 signals and is often the exclusive IL-4 receptor found in 
non-hematopoietic cells (63). The heterodimerization step is always necessary for the 
transduction of IL-4 signals (64-65).  
IL4-induced activation of STAT6 promotes gene regulation, differentiation of activated CD4 T 
cells to the Th2 phenotype, development of the Th9 phenotype (66), IL-4–induced GATA-3 
expression, production of chemokines, and production of IgE and IL-4–inducible allergic 
responses (67) . 
Another cytokine, IL-13 also activates STAT6 after binding onto the IL-4Rα chain (Figure 6) 
(68). Due to its ability to induce signaling pathways through a similar receptor complex, some 
effects in vivo are shared by both cytokines, for example, induction of Th2 responses against 
parasites and control of T cell function in allergic diseases (69). Though, these two cytokines 
present some differences such as the restricted expression of IL-4 to Th2 lymphocytes and the 
inability of IL-13 to regulate T cell differentiation deriving from the lack of IL-13 receptors in T 
lymphocytes (70). 
Regulation of CD8 T cell development, frequency and function seems to be promoted by IL-
4 as endogenously it stimulates CD8 T cell proliferation and regulates Eomes (Eomesodermin) 
expression levels (71). In addition, exogenous IL-4 induces memory-like phenotype in 
peripheral CD8 T cells (72). Thus, IL-4 negatively regulates the quality of the CD8 T cell 
response during viral infection, impairing the protective response these cells have diminishing 
perforin/granzyme-mediated cytotoxicity (73-75). However, in models of tumor immunity, it was 
previously demonstrated that higher IL-4Rα expression reduced the functional capacity of anti-
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viral CD8 T cells. IL-4 upregulates its own expression and in parallel downregulates cytotoxic 
capacity, IFN-γ production and CD8 expression during the primary activation of CD8 T cells 
(69). On the other hand, all these effects of IL-4 described above have been brought in 
question by several studies showing that IL-4 could potentiate the cytotoxic activity of CD8 T 
cells during tumor clearance, increasing tumor rejection in vivo (76). Moreover, in some cases 
IL-4 producing CD8 T cell populations displayed strong cytotoxic-T-lymphocyte activity and 
CD8 expression (77). Overall, the effect of IL-4 in CD8 T cells is not aggreed. 
 
1.8.1 Role of IL-4 in T cell development 
Regarding the role of IL-4 in thymocyte differentiation, studies in murine systems revealed 
that IL-4 blocks the differentiation of early thymocyte precursors, whereas precursor cells that 
are already committed to the differentiation process are no longer affected (78).  
In humans, IL-4 has an impact in pro-T cells by inducing proliferation and differentiation into 
functionally mature γδT cells which present a TCR repertoire similar to that of gamma delta T 
cells that can be found in post-natal thymus (79). Thus, IL-4 effect on human T cell 
development is poorly described. Nonetheless, it is known that its presence is required during 
the initial activation of naïve T cells, promoting a specific differentiation program. Acting 
through STAT6 and GATA3, IL-4 can determine Th2 cell fate originating helper cells capable 
of producing IL-4 (80). 
 
 
Figure 7. Membrane receptors and intracellular signaling pathways activated by IL-4 and/or IL-13. IL-4 
binds to the IL-4Rα subunit of the type II receptor complex, whereas IL-13 binds to the IL-13Rα1 subunit of the 
same receptor complex. Both IL-4 and IL-13, which share the IL-4Rα subunit in their cognate receptors, activate 
STAT6 which dimerises, migrate to the nucleus, and bind to the promoters of the IL-4 and IL-13 responsive genes, 
such as those associated with T-helper type 2 (Th2) cell differentiation, airway inflammation, airway 
hyperresponsiveness (AHR) and mucus production (from Vatrella, A. et al, 2014). 
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2 OBJECTIVES  
T cell development taking place in the human thymus is a process of extreme importance 
allowing differentiation and maturation of immune cells responsible for surveillance and 
response to pathogens that attack the organism. Though, the mechanisms underlying cell’s 
fate determination are still poorly described in humans.  
The main aim of this project was to elucidate the role of IL-4 in the plasticity of the CD4SP 
thymocytes subset and in CD4 T-cell lineage fate. 
The specific objectives were to: 
o Characterize the modulation of CD8 expression in human CD4SP thymocytes 
in response to IL-4 and its kinetics; 
o Compare the modulation of CD8 expression in human CD4SP thymocytes with 
that of cord blood and adult naïve CD4 T cells; 
o Study the expression of key transcription factors in human CD4SP thymocytes 
upon culture with IL-4, and the relationship with the degree of CD8 upregulation; 
o Determine the landscape of IL-4 and IL-4Rα expression in the human thymus; 
o Understand if there is a physiological role for IL-4 in CD4SP T cell differentiation.  
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3 METHODOLOGY 
 
3.1 Samples 
Thymic tissue was obtained from thymectomy during pediatric corrective cardiac surgery 
(newborns to 4-year old) at Santa Cruz Hospital, after parent’s informed consent. Study was 
approved by the Ethical Boards of the Faculty of Medicine of Lisbon, Santa Maria and Santa 
Cruz Hospitals.  
Blood was collected from volunteer healthy donors at IMM (Instituto de Medicina Molecular), 
Lisbon, Portugal. 
Cord Blood was collected in the obstetric department of the Hospital de Santa Maria, Lisbon, 
Portugal, after parent’s written informed consent. The study was approved by the Ethical Board 
of the Faculty of Medicine of the University of Lisbon. 
 
3.2 Tissue and whole blood processing 
Total thymocytes were recovered through tissue dispersion and separation on a Ficoll-Paque 
Plus (GE Healthcare) density gradient.  
T cells from peripheral and cord blood were recovered after Ficoll separation from diluted 
whole blood in PBS.  
Cell number was estimated using a Neubauer chamber and trypan blue for dead cell 
exclusion. 
 
3.3 Cell Sorting/Isolation 
From total thymocytes the cells were sorted (Table 1 and Supplementary figure 1) with purity 
>98% using FACSAria high-speed cell sorter (BD Biosciences).  
From peripheral blood, CD4 naïve and memory T cells were also FACS-sorted using 
FACSAria high-speed cell sorter (BD Biosciences) (Table 1 and Supplementary figure 2).  
From cord blood, cells were separated using the EasySep Human naïve CD4+ T cell isolation 
kit (Stemcell).  
Table 1. Definition of FACS-sorted subsets 
Sample Population Phenotype 
Thymocytes 
CD4SP TCRγδ-, CD25-, CD3high, CD4+, CD8- 
DP TCRγδ-, CD25-, CD3high, CD4+, CD8+ 
CD8SP TCRγδ-, CD25-, CD3high, CD4-, CD8+ 
PBMCs 
CD4 naïve CD4+CD3+CD8-CD45RA+CCR7+ 
CD4 memory CD4+CD3+CD8-CD45RA-/CD4+CD3+CD8-CD45RA+CCR7- 
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3.4 Cell cultures 
Sorted/isolated cells were ressuspended in complete medium (RPMI 1640 with 10% of FCS 
(thymocytes and PBMCs) or human AB serum (cord blood cells), 2 mM L-glutamine and 50 
U/ml penicillin-streptomycin). 
Thymocytes or T cells were then cultured for 7 to 14 days in the absence or presence of CM, 
IL-2 (20 U/ml), IL-4 (1, 10, 20, 50 ng/ml; R&D), IL-7 (1, 10, 50 ng/ml; R&D) or IL-13 (10, 50, 
100ng/mL) at 37°C/5% CO2. 
Some cells were re-sorted as CD4+CD8-, CD4+CD8+, CD4-CD8+ at day 7 of culture with IL-
4 and re-cultured for 7 more days in the absence or presence of IL-2 (20 U/ml) and IL-4 
(20ng/ml; R&D). 
 
3.4.1 Thymic Organ Cultures (TOCs) 
Thymic tissue blocks (diameter 1 to 2 mm) were placed on 0,8 uM isopore membrane filters 
(Millipore) in a 6-well plate containing 2 ml of TOC medium. TOCs were cultured at 37°C in 5% 
CO2 for 7 days in the presence of CM (RPMI1640, 15% FCS, 1% L-Glutamine, 1%  Non-
essential aminoacids, 1% HEPES, 1%  NaPyr, 0,5% Pen/Strep, 1% Gentamycin), IL-4 (20 
ng/ml; R&D), anti-IL-4 blocking antibody (1, 5, 10 ug/mL, eBioscience) and IgG1 isotype control 
for the IL-4 blocking antibody. On days 0 or 7 TOCs were mashed and stained, or fixed in 
formol for further immunohistochemistry analysis.  
 
3.5 Flow cytometry staining 
Surface staining was performed for 20 minutes at room temperature and always included 
fixable viability dye (FVD; eBioscience) for dead cell exclusion. Thymocytes were further fixed 
and permeabilized using an intracellular staining kit (eBioscience) and stained with intracellular 
antibodies. The antibodies used and conjugated fluorophores are specified in Table 2. At days 
0, 7 and 14 the thymocyte number per well was determined using 10-μm latex beads (Coulter), 
and cells were also analyzed by flow cytometry. Cells were acquired using LSRFortessa cell 
analyzer (BD Biosciences), and data was analyzed with FlowJo software (TreeStar).  
 
Table 2. Antibodies used and respective fluorophores 
Fluorophores Antibody Clone Brand 
FITC 
TCRγδ B1.1 
eBioscience  
CD27 0323 
Ki67* B56 
BD 
Pharmigen 
CD11c 3.9 eBioscience 
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CD14 61D3 
CD16 CB16 
CD19 HIB19 
CD123 6H6 
PE CD4 RPA-T4 
PerCp-Cy5.5 CD8a RPA-T8 
PeCy7 CD45RA HI100 
eF660 CD8β SIDI8BEF 
eF450 
CD45RA HI100 
CD127 eBioRDR5 
FoxP3* PCH101 
V500 CD3 UCHT1 BD Horizon 
- α-IL-4 MP4-25D2 eBioscience 
*Antibodies used intracellularly 
 
3.6 Immunohistochemistry staining 
Pieces of human thymic tissue were preserved in 4% formaldehyde, embedded in paraffin, 
deparaffinised and cut into 3-μm sections (Minot microtome Leica RM2145). Samples 
underwent antigen retrieval (Leica Buffer Ph9) by heat for 15 min. Samples were stained with 
the appropriate primary antibodies anti-IL-4 (single and double staining), IL-4Rα (single 
staining), Pan-cytokeratin (single and double staining) and c-kit (single staining).  
Single or double immunohistochemistry stainings were revealed by enzymatic substrate with 
horseradish peroxidase (Dako EnVision Detection Systems Peroxidase/DAB, Rabbit/Mouse 
kit (Agilent Technologies, Santa Clara, CA)) and alkaline phosphatase (EnVision G|2 
Doublestain System). Rabbit/Mouse (DAB+/Permanent Red (Agilent Technologies, Santa 
Clara, CA)) stain in brown and red, respectively.  
All slides were counterstained with Hematoxylin and mounted with Quick-D mounting medium 
(single staining) or Glycergel (double staining) from DakoPower. Bright-field images were 
acquired using a Leica DM 2500 Microscope or a NanoZoomer (Hamamatsu’s). 
 
3.7 RNA extraction, cDNA synthesis and quantification by RT-qPCR 
Transcriptional expression of lineage specific genes was analyzed by reverse transcription–
polymerase chain reaction (RT-PCR) of total RNA extracted at day 0 or day 7/9 after cytokine 
culture. 
RNA purification was performed using a ZR-Duet DNA/RNA Miniprep isolation kit (Zymo 
Research). The purified RNA was then used to synthesize cDNA using random primers and 
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SuperScript III RT (Invitrogen), according to the manufacturer's instructions. Real-time PCR 
was performed using Power SYBR green PCR master mix (Applied Biosystems) with adequate 
primers (Table 3), using GAPDH, β-actin (ACTB) and 18S as reference genes. Quantification 
was performed using an Applied Biosystems ViiA7 real-time PCR system. Results were 
expressed using the ΔCt method. 
 
Table 3. Primers used in the study 
Gene Forward Primer  Reverse Primer  
CD4 TGCCTCAGTATGCTGGCTCT GAGACCTTTGCCTCCTTGTTC 
CD8 TCCTCCTATACCTCTCCCAAAAC GGAAGACCGGCACGAAGTG 
ThPOK GTCCCCAGAGCTACGAACC AGCTTAGGTAGGCCATCAGGT 
GATA3 GCCCCTCATTAAGCCCAAG TTGTGGTGGTCTGACACTTCG 
RUNX3 AGGCAATGACGAGAACTACTCC CGAAGGTCGTTGAACCTGG 
GAPDH GGTGGTCTCCTCTGACTTCAACA GTTGCTGTAGCCAAATTCGTTGT 
18S GGAGAGGGAGCCTGAGAAACG CGCGGCTGCTGGCACCAGACTT 
ACTB CTGGCACCCAGCACAATG GCCGATCCACACGGAGTACT 
 
3.8 Graphic analysis 
Graphic analysis were performed using GraphPad Prism (v5.01) software (GraphPad 
Software Inc.) and are presented as mean±SEM (standard error of the means). 
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4 RESULTS AND DISCUSSION 
 
4.1 IL-4 induces upregulation of CD8αβ in CD4SP thymocytes 
 
Previous observations from our lab suggested that IL-4 induced the upregulation of CD8 in 
CD4SP thymocytes. We thus cultured CD4SP thymocytes with two other c cytokines, IL-2 or 
IL-7, in order to understand whether that mechanism was particular of IL-4. IL-7 was already 
described to play a role in T cell survival and development, particularly in the co-receptor 
reversal that promotes differentiation of CD8 T cells in mice  (kinetic signaling model) (28-29), 
and IL-2 represents a primary T-cell growth factor (81) and was chosen as a control.  
Our results showed that CD8 upregulation was much higher in CD4SP thymocytes treated 
with IL-4 for 7 days than in those treated with IL-2 or IL-7 (Figure 1). In contrast to what was 
expected, IL-7 had lower capacity than IL-4 to upregule CD8 in CD4SP thymocytes, and 
generated mostly DP cells. IL-2 had no specific pattern of CD8 upregulation in CD4SP 
thymocytes, indeed representing a control. Of note, the same effect of IL-4 was found when 
CD4SP cells were cultured with two other recombinant IL-4s  (Supplementary figure 4). 
 Our results show that, in humans, co-receptor reversal may be induced by IL-4, and indicate 
a possible role for IL-4 in T cell development.  
 
 
Figure 1. IL-4-induced upregulation of CD8 in CD4 thymocytes. FACS-sorted CD4SP thymocytes were 
cultured for 7 days with IL-2 (20U/mL), IL-4 (20ng/mL) or IL-7 (10ng/mL). CD8α upregulation and generation of DP 
and CD8SP cells from CD4SP thymocytes was increased upon IL-4 exposure as compared to the other cytokines 
tested.  
 
We further tested several concentrations of IL-4 or IL-7 in order to understand their capacity 
of upregulating CD8 on CD4SP T cells, as the dose of IL-7 could be insufficient to induce a 
complete co-receptor reversal. CD4SP cells were cultured for 7 days in the absence or 
presence of IL-2 or of different concentrations of IL-4 or IL-7. Analyses at day 7 revealed that 
CD8 upregulation on CD4SP thymocytes was lower for IL-7 than for IL-4 independently of the 
concentration tested, indicating that the effect of IL-7 was indeed less marked (Figure 2). In 
7 Days 
CD4+CD8-CD3++ IL-2 IL-4 IL-7 
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addition, we observed no difference in the frequency of DP T cells generated with the three 
highest concentrations of IL-4 tested (Figure 2A). On the other hand, an increasing number of 
CD8SP T cells were generated in parallel with increasing concentrations of IL-4, with exception 
of the highest concentration (50ng/mL) (Figure 2B).  We thus chose IL-4 at 20ng/mL as the 
ideal concentration for future experiments, since it represented the concentration that yielded 
higher levels of CD8SP cells with less variation.  
 
 
 
 
 
 
 
 
 
 
Figure 2. Dose dependent response to IL-4. FACS-sorted CD4SP thymocytes were cultured for 7 days with 
Media (CM), IL-2 (20U/mL), IL-4 (1, 10, 20 and 50ng/mL) or IL-7 (1, 10 and 50ng/mL) in order to determine the 
dose-dependent response to each cytokine. Graphs represent the frequency of DP (A) or CD8SP (B) thymocytes 
at day 7. IL-7 was not able to induce the same extent of CD8 upregulation as IL-4, independently of the 
concentration used. 20ng/mL was the ideal concentration of IL-4 to induce CD8SP T cells from CD4SP T cells, and 
was the concentration chosen for future experiments. Values are represented as mean±SEM (n=3). 
 
Mature functional CD8 T cells express on the surface a complex of two chains, α and β which 
are the products of two closely linked but separate genes (82-84). As data so far had been 
obtained using the CD8α antibody, which is the molecule routinely identified in CD8 T cell 
analyses, we further wanted to determine whether the CD8β chain was also being expressed 
in the surface of IL-4-treated CD4SP T cells. Our results confirmed that the heterodimer CD8αβ 
was expressed on the surface of the newly generated CD8 T cells (Figure 3) thus indicating 
that IL-4 is abble not only of inducing activation of thymocytes but also induces a co-receptor 
reversal from CD4+CD8- into CD4-CD8+ T cells. 
 
 
 
 
 
 
A B 
C D 
A B 
7 Days 
IL-4 
CD4+CD8-CD3++ Within DPs Within CD8SP 
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Figure 3. IL-4 induces upregulation of the CD8αβ heterodimer. FACS-sorted CD4SP thymocytes were 
cultured for 7 days with Media, IL-2 (20U/mL), IL-4 (20ng/mL) or IL-7 (10ng/mL) and by flow cytometry expression 
of both CD8α and β chains was assessed. Results showed that both CD8 chains were upregulated in CD4SP 
thymocytes cultured with IL-4. Values are represented as mean (n=4). 
 
4.2 IL-13 is not capable of upregulating CD8 
 
Since Interleukin-13 (IL-13) binds to the IL-13Rα1, promoting dimerization with IL-4Rα (85), 
it was plausible to think that IL-13 could induce similar CD8 upregulation in CD4SP T cells. 
However, we saw no capacity of upregulation of CD8α on CD4SP thymocytes by IL-13 
(Supplementary figure 5). This can be explained by the reported absence of IL-13R in human 
T cells (86).  
 
4.3 Role of proliferation in IL-4-induced CD8 upregulation on CD4SP thymocytes 
 
To gain further insight on the mechanisms behind IL-4-induced CD8 upregulation we asked 
whether it was driven by proliferation. Using the proliferation marker Ki67 we found that, 
although there are some cells proliferating, CD8 upregulation can be observed in IL-4-treated 
CD4SP thymocytes in the absence of proliferation (Figure 4A). Of note, IL-2 did not induce 
proliferation, while IL-4 and IL-7 mostly induced the proliferation of CD8- thymocytes (Figure 
4B). 
Overall, we can attest that proliferation does not seem to be necessary for IL-4-promoted co-
receptor reversal. 
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Figure 4. CD8 upregulation is observed in the absence of proliferation. FACS-sorted CD4SP thymocytes 
were cultured for 7 days with IL-2 (20U/mL), IL-4 (20ng/mL) or IL-7 (10ng/mL) in order to evaluate cell proliferation 
using the Ki67 marker. A. CD8 upregulation appears to be independent of proliferation, as most of CD8SP T cells 
generated do not express the proliferation marker Ki67. B. IL-4 and IL-7 induced, majorly, upregulation of CD8- 
thymocytes. Values are represented as mean±SEM (n=3). 
 
4.4 CD8 upregulation potential decreases with CD4 T cell maturation 
 
In order to evaluate the ability of CD4SP thymocytes at different stages of 
maturation/commitment to perform co-receptor reversal we analyzed the various stages of 
CD4 development (as described by Spits, 2002) and stimulated these subsets with IL-4 for 7 
days. We sorted CD4+CD3hi CD27-CD45RA- (lineage-uncommitted cells), 
CD4+CD3hiCD27+CD45RA- (CD4-helper lineage-committed cells) and 
CD4+CD3hiCD27+CD45RA+ (CD4-helper lineage-committed cells ready to egress the human 
thymus) thymocytes and cultured these three subsets with IL-4, IL-2 or IL-7 for 7 days. 
As shown on Figure 5, the potential to generate CD8SP thymocytes was highest in the more 
immature subset, and this ability was gradually lost with increasing CD4 commitment. Thus, 
CD27-CD45RA-  CD4SP thymocytes were the more plastic cells, followed by CD27+CD45RA- 
and by CD27+CD45RA+, which still retained some capacity to undergo co-receptor reversal, 
although very low. Importantly, co-receptor reversal was observed even in CD27+ CD4SP 
thymocytes, indicating that CD27 may not be such a definitive marker for human CD4 T cell 
commitment. 
 
 
Figure 5. The potential to induce co-receptor reversal is gradually lost with increasing CD4SP maturation. 
FACS-sorted CD4+CD3hiCD27-CD45RA- (A), CD4+CD3hiCD27+CD45RA- (B) or CD4+CD3hiCD27+CD45RA+ 
(C) thymocytes were cultured for 7 days with Media, IL-2 (20U/mL), IL-4 (20ng/mL) or IL-7 (10ng/mL). A. Sorted 
thymocyte subsets at day 0 according to human the CD4-lineage commitment developmental stages. B. We 
observed a decreasing capacity of inducing the CD8SP phenotype in parallel with an increase in the CD4SP 
maturation. Values are represented as mean±SEM (n=3). 
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4.5 Co-receptor reversal capacity is lost in the periphery 
 
T cells leaving the thymus incorporate the peripheral naïve T cell pool. We asked whether 
CD4 T cells in the periphery retain the ability to upregulate CD8 in the presence of IL-4, and 
whether this ability was age-dependent. With this purpose, isolated naïve CD4 T cells from 
cord blood or naïve and memory CD4 T cells from adult blood were cultured with IL-4 for 7 
days, and CD8 expression was assessed by flow cytometry. Newborn cord blood naïve CD4 
T cells, sorted as untouched CD4 naïve T cells, were still able to upregulate CD8 upon IL-4 
exposure but did not complete co-receptor reversal (Figure 6A). In contrast, naïve and memory 
CD4 T cells from adult blood showed a complete loss of CD8 upregulation capacity (Figure 
6B). It is possible that the kinetics of CD8 upregulation is slower in the periphery, and this could 
be addressed by prolonging the cultures. Nonetheless, our results support a continuous loss 
of plasticity of CD4 T cells from the thymus to the periphery, both with differentiation and with 
age.  
 
 
 
 
 
 
 
 
 
  
Figure 6. The capacity to undergo co-receptor reversal is gradually lost in the periphery. A. CD4 T cells 
from cord blood were separated using the EasySep Human naïve CD4+ T cell isolation kit and cultured for 7 days 
with IL-4 (20ng/mL). CD4 T cells retain some CD8 upregulation capacity, but generate only DP T cells; B. Naïve 
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and memory CD4 T cells from adult blood were FACS-sorted as CD4+CD3+CD8-CD45RA+CCR7+ (naïve) or  
CD4+CD3+CD8-CD45RA-/CD4+CD3+CD8-CD45RA+CCR7- (memory) and were cultured with IL-4 (20ng/mL) for 
7 days. CD4 T cells from adult blood lost the capacity to undergo co-receptor reversal, irrespective of the maturation 
stage. 
 
4.6 CD8 expression is stable upon IL-4 removal 
 
We next investigated the stability of the CD8 upregulation and of the co-receptor reversal 
induced by IL-4 in CD4SP thymocytes. 
In order to do so, we cultured CD4SP thymocytes with IL-4 for 7 days, and then sorted the 
CD4+CD8-, CD4+CD8+ and CD4-CD8+ populations generated and cultured them separately 
for 7 more days with IL-4 or IL-2, which we have confirmed does not significantly induce CD8 
expression. 
Our results showed that sorted CD8SP cells maintained their phenotype after 7 days of 
culture in the absence of IL-4 (IL-2 condition), including CD8α and β chain expression, 
supporting the stability of the co-receptor reversal (Figure 7). 
Interestingly, DPs with IL-4 continued to proceed to the CD8SP phenotype, as did to some 
extent CD4SP cells, which means that the capacity of CD8 upregulation in the presence of IL-
4 was not lost. Thus, as the co-receptor reversal was sparse in time, it may require more or 
less stimulation possibly depending on the degree of CD4SP commitment, in accordance with 
our previous results. 
Surprisingly, when analyzing the DP T cells cultured for 7 days without IL-4 stimuli (but with 
IL-2), we observed a loss of CD8 expression. This suggests that co-receptor reversal is a two 
directional process and that the DP stage constitutes a transitory phase of activation only.  
 
Figure 7. IL-4-induced CD8SP cells maintain the acquired phenotype without continuous IL-4 stimuli. 
FACS-sorted CD4 T cells were cultured in IL-4 (20ng/mL) for 7 days. At day 7 CD4, DP and CD8 T cells were again 
FACS-sorted and cultured for 7 more days in IL-2 (20U/mL) or IL-4 (20ng/mL). CD8SP cells maintained the acquired 
phenotype without IL-4 stimuli. DPs and CD4SP cells cultured in IL-4 for 7 more days maintained the ability to 
upregulate CD8. However, DPs cultured didn’t seem fully committed to their phenotype, as they revert to CD4SP 
cells upon IL-2 culture. 
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4.7 IL-4 induces modulation of lineage-specific genes 
 
Lineage commitment is highly regulated at the transcriptional level (34-56). To gain further 
insight into the phenotypically characterization of generated CD8 T cells we assessed their 
expression of CD4 and CD8, as well as the expression of key transcription factors driving 
lineage specification and commitment: ThPOK and  GATA3 (commitment to CD4) and RUNX3 
(commitment to CD8). To do so we sorted CD4SP thymocytes and cultured them with IL-4 for 
7 days. At days 7/9 CD4SP, DP and CD8SP cells were once again sorted and cell pellets were 
stored for further RNA purification. Gene expression was assessed by real time RT-PCR. 
In agreement with the upregulation of CD8 protein assessed by flow cytometry, we found an 
increase in CD8 gene expression in DP and CD8SP cells generated in culture (Figure 8). In 
accordance with the literature (26), and with the loss of commitment towards the CD4 lineage, 
ThPOK levels of expression were decreased in newly generated CD8 T cells, as well as CD4 
gene expression. Indeed, CD4, CD8 and ThPOK levels of CD8 T cells at day 7/9 were not very 
different from day 0 levels of these genes, in ex vivo CD8 T cells (Figure 8). Of note, ThPOK 
levels in DP were comparable to those found in CD4SP thymocytes after IL-4 culture, 
supporting the uncommitment of newly-generated DP cells to the CD8SP lineage, as indicated 
by the loss of the CD8 expression in DP upon IL-4 removal (Figure 8). 
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Surprisingly, GATA3 and RUNX3 expression wasn’t altered with IL-4 culture, indicating that 
these transcription factors may not be playing an essential role in IL-4 induced co-receptor 
reversal. 
Overall, the modulation of lineage-related genes found suggests that IL-4 induced real 
commitment toward the CD8 lineage fate.  
In relation to the predicted kinetic signaling model in mice (50), being this mechanism a 
possible co-receptor reversal in humans it should be highly transcriptionally regulated and IL-
4 may be the force inducing this mechanism. 
 
Figure 8. IL-4 induces modulation of lineage-specific genes. FACS-sorted CD4SP cells were cultured for 7 or 
9 days with IL-4 (20ng/mL). CD4, DP and CD8 T cells were then sorted at day 7/9, the RNA was extracted and 
cDNA was synthesized by retro transcription. Gene expression of day 0 or day 7/9 cells was assessed by real time 
PCR. Generated CD8SP T cells present an increased expression of CD8, and decreased expression of CD4 and 
ThPOK. Values are represented as mean±SEM (n=3). 
 
4.8 IL-4 is mainly present in the medulla of the human thymus 
 
In order to determine whether there might be a physiological role for IL-4 in CD4SP T cell 
differentiation we assessed the expression of IL-4 and of its receptor in the human thymus by 
immunohistochemistry.  
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Previous studies, in which sections of  fresh human  thymus were hybridized in situ with RNA 
probes for IL-4, have already located this cytokine in the Hassall's Corpuscle in the medulla of 
the thymus (87). 
To optimize the anti-IL-4 and anti-IL-4Rα antibodies for immunohistochemistry we tested 
different epitope retrieval procedures (pH6 vs. pH9, microwave (800W) for 15 minutes vs. 
water bath for 20 minutes vs. no antigen retrieval) and several dilution factors, always after 
total protein blockage. For the anti-IL-4 antibody, we determined the best conditions to be heat-
induced antigen retrieval (HIER; 800W for 15 minutes) at pH9 and a dilution factor of the 
primary antibody of 1:20. With the anti- IL-4Rα antibody we could not obtain reliable results, 
and thus show no results.  
In our assay IL-4 expression was found specifically in the medulla (M) of the human thymus, 
near Hassall’s Corpuscles (HC), and not in the cortical (C) region (Figure 9A-D). This 
observation fits our data of a role for IL-4 in CD4SP thymocyte differentiation, since mature 
thymocytes are also present in the medulla. 
We showed our slides to a trained pathologist who suggested that some of the IL-4 stained 
cells could be mast cells and epithelial reticular cells (ERC). 
To further try to identify the cells producing IL-4, thymic sections were stained with IL-4 and 
counterstained with toluidine blue, which stains specifically the cytotoxic granules of mast cells 
in purple and the nuclei in blue, since these cells are known to produce IL-4 (88). Double 
immunohistochemistry was not successful as the IL-4 staining appeared to be very aggressive 
and inhibited the oxidation and stain of the mast cell granules. To overcome this we resorted 
to two sequential sections (3μM thickness) in order to compare IL-4 and toluidin blue single 
stainings. Although the tissue showed the same overall structure in the two sections, the 
identification of the same cell in two sections was not possible. We thus optimized a sequential 
protocol in the same section with intermediate data acquisition overcoming the problem of the 
aggressiveness of IL-4 staining towards the toluidine blue staining. This method allowed us to 
identify the same cell in the two pictures. Though, we could not find co-localization of IL-4 and 
toluidine blue staining, possibly indicating that mast cells are not the main IL-4 producers in 
the human thymus (data not shown). 
To further confirm the lack of results with the toluidin blue staining we used sequential 
sections to stain for IL-4 and c-Kit, a mast/stem cell growth factor receptor. Once again no co-
localization was found supporting the previous assumption that mast cells are not producing 
IL-4 in the human thymus (Figure 9E-F). 
We performed a double staining for IL-4 and Pan-cytokeratin, an antibody for keratin-
containing intermediate filaments found in the intracytoplasmic cytoskeleton of epithelial tissue, 
in order to determine if epithelial reticular cells (ERC), found mainly in the medulla of the human 
thymus and responsible for activating T cells in the presence of pathogens, were producing IL-
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4 in the human thymus. As the two antibodies stained in brown and red, respectively, co-
localization was not possible. Thus, we also used the method of sequential sections to single 
stain for IL-4 and Pan-cytokeratin. Results show co-localization of Pan-cytokeratin and IL-4 
antibodies, thus indicating that reticular cells are producers of IL-4 in the human thymus and 
may be responsible for the co-receptor process (Figure 9F-G). Further studies require a more 
direct assessment of the expression of IL-4 and of its receptor. This could be achieved by 
performing RT-qPCR with cDNA from sorted thymic subsets (89) (such as TECs, mast cells, 
TN, DP, CD4SP and CD8SP thymocytes, TCRγδ, DCs, B and NK cells or macrophages) in 
order to determine the transcriptional levels of IL-4 and IL-4Rα in each cell type.   
Also, stimulation of thymocytes with PMA-ionomycin and brefeldin (method used to induce 
activation of T cells and production of cytokines followed by accumulation of these products 
inside the cells by inhibition of their export with brefeldin) and subsequential analysis by flow  
cytometry using an anti-IL-4 antibody may be another method to determine the cells producing 
IL-4 in the human thymus. 
Figure 9. IL-4 is mainly found in the medulla of the human thymus. Thymic tissue was embedded in paraffin 
and cut into 3-μm sections. Samples were stained with the appropriate anti-IL4, C-kit and Pan-cytokeratin primary 
antibodies and counterstained with Harris's hematoxylin. Epitope retrieval was performed at pH 9. Images were 
acquired using a Leica DM2500 microscope or a NanoZoomer. A. The negative control did not stain (amplification 
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of 100x). IL-4 was found in the medulla (M) of the human thymus (amplification of 100x and 200x, respectively) (B, 
C), preferencially near Hassal corpuscles (HC) (amplification of 400x and 200x, respectively)  (D, F). E, F. Staining 
with c-kit showed no co-localization with IL-4 (amplification of 200x), while pan-cytokeratin staining co-localized with 
the IL-4 staining (amplification of 200x) (F, G). 
 
4.9 IL-4 did not produce an effect on T cell differenctiation in Thymic Organ Cultures 
(TOCs) 
 
We used thymic organ cultures (TOCs), which represent organotypic cultures that support 
human T cell differentiation (90), to further try to assess a possible physiological role of IL-4 in 
human T cell development.  
With this purpose we cut 1-8mm3 pieces of thymic tissue, cultured them with appropriate 
media in the absence of presence of IL-4, blocking anti-IL-4 antibody or IgG1 (as an isotype 
control for the anti-IL-4 blocking antibody) for 7 days, and assessed thymocyte phenotype by 
flow cytometry. 
We confirmed that the blocking anti-IL-4 antibody was able to reduce CD8 upregulation on 
CD4SP thymocytes in culture (Supplementary Figure 6). Of note, these results further support 
that CD8 upregulation constitutes a direct effect of IL-4 on CD4SP thymocytes. 
Our results show that IL-4 blockage did not induce a decrease in the frequency of DP or 
CD8SP thymocytes as compared to the control without cytokines or to the IgG1 control (Figure 
10). This might be due to a low dose of blocking antibody, which may not be enough to inhibit 
the natural thymic mechanisms taking place in TOCs (as we used the same concentration of 
this antibody as with the purified CD4SP thymocytes). In addition, IL-4 did not have a 
noticeable effect on the frequency of CD8SP thymocytes, and only induced a slight increase 
in DP thymocytes. Since we used the same concentration of IL-4 as in sorted cells, it may not 
be enough to induce the same effect in TOCs. Furthermore, longer cultures might be 
necessary for an effect of IL- 4 blocking to be revealed. As a whole, this experiment needs to 
be further optimized. 
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Figure 10. IL-4 did not produce an effect on human TOCs. TOCs (1-8mm3 pieces of human thymic tissue) 
were cultured in membranes with appropriate media, in the absence or presence of IL-4 (20ng/mL), blocking anti-
IL-4 antibody (1ug/mL) or IgG1 antibody. None of the conditions induce a significant alteration of the frequency of 
DP or CD8SP thymocytes in TOC. Values are represented as mean±SEM (n=3). 
 
Collectively our results illustrate a role for IL-4 in the human T cell development and 
differentiation, specifically in driving the co-receptor reversal during CD4/CD8 lineage 
commitment in the human thymus, a mechanism unknown until now.  
Besides the already described roles of IL-4 in B cell immunity (91), CD8 T cells activation and 
induction of their responses (92), its relevance in the human immune system is now taken to 
extreme as it seems to be implicated in generating and differentiating T cells. 
Therefore, a better understanding of the effects of this cytokine is required. 
 
4.10 Future perspectives 
 
Further studies should address the pathways involved in IL-4 signaling responsible for the 
CD8 upregulation, possibly using signaling inhibitors in the cultures with IL-4 (93). This will 
allow us to identify the exact signaling pathway used by IL-4 in order to perform the co-receptor 
reversal from CD4 T cells to CD8 T cells. 
Additional studies should also assess the functional capacity of the generated CD8 T cells. 
In order to determine their cytotoxic/effector-function we suggest measuring the expression of 
cytolitic factors such as Granzyme-B, IFN-γ and Perforin (94) upon TCR stimulation, or the 
cytotoxic capacity of CD8 T cells using target cell lines (95). 
Also, as it is known that an imprinted genetic circuitry establishes identities of helper and 
cytotoxic lineages (96) it would be important to understand what are the epigenetic and 
chromatin-mediated mechanisms involved in CD4/CD8 lineage commitment. Measurement of 
DNA/histone acetylation and methylation are also required. 
Finally, we acknowledge the importance of testing mouse populations in order to understand 
if a similar CD8 upregulation can happen in murine thymocytes. 
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5. CONCLUSION 
 
Understanding the basis for CD4/CD8-lineage choice in the thymus is central to our 
understanding of thymocyte development. Therefore, CD4/CD8-lineage choice is one of the 
most intensively studied and debated lineage decisions in immunology. The majority of the 
studies approach these mechanisms in mice models, and so little is known in human.  
In our study we aimed to understand the role of IL-4 in T cell lineage decision. Previous 
studies had already stressed the notion of IL-4 as a promoter of CD8 T cell response (97) 
demonstrating that CD8 T cell expansion strongly relies on IL4-Rα signaling (98). Despite this, 
there was no previous indication for a major role of IL-4 in T cell development. In fact, Park et 
al, had already tested, in mice, stimulating CD4 T cells with IL-4 and excluded a possible strong 
role for IL-4 in this matter when compared to IL-7. 
Our experiments revealed that IL-4 is able to generate DP and CD8SP cells from CD4SP 
thymocytes upon 7 days of culture, including from CD4-committed CD4+CD27+ mature cells 
(17). These results indicate that T cell development and furthermore lineage commitment 
taking place in the human thymus is not an irreversible process as SP thymocytes present a 
certain degree of plasticity, allowing them to undergo co-receptor reversal upon appropriate 
stimuli, such as IL-4, as is described here. Experiments with cord blood and peripheral blood 
CD4 T cells show gradual loss of this capacity, thus indicating that T cell plasticity potential is 
higher in the human thymus, where commitment takes place, and is lost in the periphery.  
Generated CD8SP cells seem to be stable, as they maintained their phenotype after 7 days 
of culture without IL-4 stimuli, meaning that this process is not just cell activation but a stable 
reversal of lineage commitment. Also, we realized that CD4 T cells that didn’t undergo co-
receptor reversal on the first 7 days of culture, maintained this ability 7 days later with new IL-
4 stimulus, thus demonstrating that most of CD4 T cells have some degree of plasticity though 
its activation towards co-receptor reversal is sparse in time and may require more or less 
stimulation. Additionally, as generated DP T cells cultured without IL-4 stimuli returned to a 
CD4 phenotype, we can conclude that the co-receptor reversal is a two directional process 
and the DP stage emerges as a transitory phase of activation only.  
Since CD4/CD8 lineage fate depends highly on transcriptional regulation, we analyzed the 
expression of some of the determining lineage-specific genes. We observed a decreased 
expression of CD4 and ThPOK and an increased expression of CD8 in IL-4-induced CD8SP 
thymocytes, indicating lineage-specific gene expression modulation by IL-4 towards a CD8 
phenotype. Of note, we found considerable expression of ThPOK in IL-4-induced DP 
thymocytes, in agreement with their low ability to preserve the DP phenotype upon IL-4 
removal from culture, further supporting the transient nature of this population. 
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Importantly, in agreement with a possible physiological role for IL-4 in T cell development, 
expression of this cytokine was found in the medulla of the human thymus by 
immunohistochemistry. However, our preliminary experiments using TOCs where IL-4 was 
blocked using a specific antibody, or where exogenous IL-4 was added, showed no significant 
differences in the frequency of CD8+ thymocytes. 
 Cytotoxic CD8 SP T cells play a critical role in adaptive immunity by destroying virally infected 
or malignant cells. Cytoablative procedures to treat malignancies or HIV infection results in the 
destruction of T cells, leading to a period of immunodeficiency and a concomitant increase in 
opportunistic infections. While hematopoietic stem cell (HSC) transplants can reconstitute the 
entire immune system, T cells are the slowest population to recover or may never recover at 
all. The ability to direct human T cells towards a mature functional phenotype raises the 
possibility of establishing cell-based treatments for T cell immunodeficiencies by rapidly 
restoring CD8 T cell effector function, thereby mitigating the risks associated with opportunist 
infections. In the long run, IL-4 might rise as a possible in-vitro generator of cytotoxic-CD8 T 
cells to be used in the clinic.  
In conclusion, our study provides evidence for a role of IL-4 in CD4 T cell plasticity and co-
receptor reversal. Furthermore, it describes an important model for the study of T cell lineage 
commitment in the human thymus. 
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APPENDIX 
 
 
Supplementary figure 1. Gating strategy for sorting the thymocyte subsets CD4SP, DP and CD8SP.  
  
 
 
 
 
 
Supplementary figure 2. Gating strategy for sorting peripheral blood mononuclear cell (PBMC) subsets according 
to naïve and memory CD4 T cells. 
 
 
 
 
 
 
Supplementary figure 3. Gating strategy at day 0 upon FACS-sorting of CD4SP, DP and CD8SP thymocytes.  
 
 
Supplementary figure 4. Different recombinant IL-4s present the same effect inducing CD8 upregulation 
in CD4SP thymocytes. FACS-sorted CD4SP thymocytes were cultured with three different recombinant IL-4s (two 
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IL-4s from R&D (old and new batch in left and middle panels, respectively) and an IL-4 from Peprotech (right 
pannel)), all at 20ng/mL for 7 days. All IL-4s had a comparable effect on CD8 upregulation in CD4SP thymocytes. 
 
Supplementary figure 5. IL-13 is not capable of upregulating CD8. FACS-sorted CD4SP cells were cultured 
with IL-13 at 10nM, 50nM or 100nM for 7 days, and compared to Media (MC) or IL-4 (20ng/mL). No capacity of IL-
13 to upregulate CD8α was found. Values are presented as mean±SEM (n=1). 
 
Supplementary figure 6. The anti- IL-4 antibody reduces CD8 upregulation by IL-4 in CD4SP thymocytes. 
FACS-sorted CD4SP cells were cultured with IL-4 (20ng/mL) in the absence or presence of blocking anti-IL-4 
antibody at three different concentrations (1, 5 and 10ug/mL) for 7 days. Blocking anti-IL-4 antibody strongly 
inhibited IL-4-promoted CD8 upregulation. 
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